Numan, a digital platform offering healthcare support, has extended its Series B round with a $60m (£44.7m) investment.
The new funding comes at a period of rapid growth for the health tech, which recently doubled its year-on-year revenue to $90m (£67.2m).
Numan’s digital health platform includes consultations with clinicians, medication prescriptions, behavioural health coaching and access to an app for tracking progress and managing treatments.
The company previously raised a Series B investment round of £30m back in 2021.
“Our latest funding is a testament to both our commercial performance and belief in our long-term vision for providing personalised, preventative health at scale,” said chief executive Sokratis Papafloratos.
“We are now perfectly positioned to expand our reach, deepen our clinical capabilities, and accelerate innovation to help our patients live happier, healthier, longer lives.”
According to Papafloratos, the platform has seen an “explosion in demand” in the past 18 months.
“This interest fuelled our growth and success in both reaching and maintaining profitability. That’s why we believe now is the time to invest in scaling what works and innovating for the future of healthcare.”
The new funding package includes a $30m (£22.4m) equity investment led by Big Pi Ventures with support from Endeavor Catalyst, White Star Capital and Novator Partners.
“Numan has demonstrated exceptional growth and a clear vision to tackle some of healthcare’s most pressing challenges, from obesity to hormonal health,” said Big Pi Ventures partner Nick Kalliagkopoulos.
“The team’s focus on preventative care, patient engagement, and scalable technology sets Numan apart in the digital health sector. We’re confident that this infusion of capital will help Numan consolidate its leadership in the UK and pave the way for international expansion.”
The fundraise also includes access to $27m (£20.1m) in growth capital from HSBC Innovation Banking.
The post Digital health group Numan extends Series B with £45m appeared first on UKTN.
